Headerlogotextwithshieldsshadowed

Tumor Course Faculty – 2022

Course Director

Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Radiation Oncology (Tumor Biology), Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA

Faculty

  • George Coukos, M.D., Ph.D., Professor; Director of Hi-TIDe - Human integrated tumor immunology discovery engine; Head of the Department of oncology; Department of oncology UNIL CHUV, Ludwig Institute for Cancer Research, Lausanne, Switzerland
    Lisa M. Coussens, Ph.D., Hildegard Lamfrom Chair in Basic Science; Professor and Chair, Cell and Developmental Biology; Associate Director for Basic Research, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
    Chi Van Dang, M.D., Ph.D., Scientific director, Ludwig Institute for Cancer Research; Professor, Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA, USA
    Nir Hacohen, Ph.D., Director, Massachusetts General Hospital Center for Cancer Immunotherapy, Member, Broad Institute, Boston, MA, USA
    Rakesh K. Jain, Ph.D., Andrew Werk Cook Professor of Tumor Biology, Harvard Medical School; Director, E.L. Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    Carl H. June, M.D., Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine; Director of the Center for Cellular Immunotherapies; Director of the Parker Institute for Cancer Immunotherapy; University of Pennsylvania, Philadelphia, PA, USA
    Arlene Sharpe, M.D., Ph.D., George Fabyan Professor of Comparative Pathology; Chair, Department of Immunology, Harvard Medical School; Leader, Cancer Immunology Program, Dana- Farber/Harvard Cancer Center; Co- Director, Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women’s Hospital, Boston, MA, USA
    George W. Sledge, Jr., M.D., Professor of Medicine and Chief, Division of Oncology, Stanford University Medical Center, Stanford, CA, USA
    Mario L. Suva, M.D., Ph.D., Associate Professor of Pathology, Massachusetts General Hospital and Harvard Medical School Associate Member at the Broad Institute of MIT and Harvard, Co-Director, Cancer Program, Harvard Stem Cell Institute, Boston, MA, USA
    Michael D. Taylor, M.D., Ph.D., F.R.C.S., Principal Investigator, The Arthur and Sonia Labatt Brain Tumour Research Centre; Senior Scientist, Developmental & Stem Cell Biology; Associate Professor, Departments of Surgery and Laboratory Medicine and Pathobiology, University of Toronto, Ontario, Canada
    David A. Tuveson, M.D., Ph.D., Professor and Director, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA
    Matthew Vander Heiden, M.D., Ph.D., Associate Professor of Biology, Massachusetts Institute of Technology; Associate Director, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA
    Jennifer A. Wargo, M.D., Professor, Surgical Oncology & Genomic Medicine; Program Director for PRIME TR, MD Anderson Cancer Center, Houston, TX, USA
    Robert A. Weinberg, Ph.D., Daniel K. Ludwig Professor for Cancer Research at Massachusetts Institute of Technology, Director of the Ludwig Center of the MIT, and American Cancer Society Research Professor

Tumor Course Faculty (1986-present)